2022
DOI: 10.1093/jpids/piac033
|View full text |Cite
|
Sign up to set email alerts
|

Group B Streptococcal Cellulitis-Adenitis Syndrome in Infants: Insights From 24 Years of Experience

Abstract: This series of 28 infants with group B streptococcal (GBS) cellulitis-adenitis from a single institution over 24 years offers insights important to the early recognition, spectrum of findings, and optimal management of this rare manifestation of invasive GBS disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 12 publications
0
2
0
Order By: Relevance
“…Treatment consists of initial broad-spectrum antibiotics. 22,23 Radiographic imaging might help differentiate between GBS parotitis and GBS cellulitis-adenitis syndrome, as shown in our case, however, diagnostic work-up and initial treatment are identical for both modalities. Maternal GBS colonization is an important risk factor for GBS disease.…”
Section: Discussionmentioning
confidence: 67%
“…Treatment consists of initial broad-spectrum antibiotics. 22,23 Radiographic imaging might help differentiate between GBS parotitis and GBS cellulitis-adenitis syndrome, as shown in our case, however, diagnostic work-up and initial treatment are identical for both modalities. Maternal GBS colonization is an important risk factor for GBS disease.…”
Section: Discussionmentioning
confidence: 67%
“…A systemic review conducted in 2018 found 24 published studies accounting for a total of 40 patients with GBS cellulitis and identified prematurity as a likely risk factor 1. Since then, five additional studies have been published, each presenting cases of GBS-associated soft tissue infection with relatively similar approaches to medical and surgical management but none focusing specifically on the issue of postsurgical scar management in the context of early-onset GBS disease 7–11…”
Section: Discussionmentioning
confidence: 99%